15,168 Shares in Puma Biotechnology, Inc. $PBYI Bought by Ethic Inc.

Impact · against what's priced in

The acquisition of a small position in Puma Biotechnology by Ethic Inc. is not a price catalyst. The investment size is negligible relative to the company's market capitalization and does not signal a material shift in institutional sentiment.

PBYI+0.02

No priced-in read yet

In context

Ethic Inc. acquired 15,168 shares valued at approximately $51,000, but the position size is too small to move the needle on valuation.

Read from the article alone

• biotechnology▲42%
• 13f
• PBYI
• biopharmaceuticals
• institutional investors
• portfolio change

Top 1 mover · tap to explore